Measuring Biologic Resilience in Older Cancer Survivors.

Autor: Sedrak MS; City of Hope National Medical Center, Duarte, CA., Gilmore NJ; University of Rochester Medical Center, Rochester, NY., Carroll JE; University of California, Los Angeles, David Geffen School of Medicine, Jonsson Comprehensive Cancer Center, Jane & Terry Semel Institute for Neuroscience & Human Behavior, Department of Psychiatry & Biobehavioral Sciences, Cousins Center for Psychoneuroimmunology, Los Angeles, CA., Muss HB; Department of Medicine and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC., Cohen HJ; Duke University Medical Center, Durham, NC., Dale W; City of Hope National Medical Center, Duarte, CA.
Jazyk: angličtina
Zdroj: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Jul 01; Vol. 39 (19), pp. 2079-2089. Date of Electronic Publication: 2021 May 27.
DOI: 10.1200/JCO.21.00245
Abstrakt: Competing Interests: Mina S. SedrakResearch Funding: Novartis, Seattle Genetics, Lilly, PfizerNo other potential conflicts of interest were reported.
Databáze: MEDLINE